A generic storage rule cannot establish that a prepared Epitalon product remains suitable for a proposed use. The relevant evidence must describe the exact material, formulation, container and conditions.
Separate chemical stability from overall quality
The FDA chemistry review discusses characterization and formulation uncertainties for Epitalon-related substances. Data about a bulk material cannot automatically validate a different finished preparation.
Chemical persistence is also only one question. Identity, amount, impurities and microbiological quality need appropriate assessment. A preparation can look unchanged while important properties remain unknown.
An online claim that every peptide lasts the same number of days therefore answers more than its evidence can support.
Freezing is not a universal repair strategy
A forum suggestion to divide, freeze or otherwise manipulate a preparation does not establish that it will remain within suitable specifications. That would require product-specific evidence and appropriate professional controls.
Likewise, using the rest of a container to avoid waste does not make additional exposure medically justified. The cost already paid should not determine a clinical duration.
A report of feeling an effect from stored material does not test the container's composition or exclude contamination. Perceived activity and acceptable quality are different conclusions.
Ask for the evidence behind the instruction
A useful stability claim identifies the tested preparation, storage conditions, time points, analytical methods and acceptance criteria. It should be traceable to the actual product rather than an unrelated study or screenshot.
For a legitimately prescribed preparation, the dispensing pharmacist should address its storage instructions and any uncertainty about handling. Do not replace that advice with a generic internet chart.
For research-only material, this article supplies no preparation recipe, storage timetable or permission to administer it. The unresolved suitability question comes before any proposed deadline.
The practical answer is product-specific. If that evidence is unavailable, choosing a confident number would hide the uncertainty rather than solve it.